Villasanta, Italy

Laura Belvisi


 

Average Co-Inventor Count = 11.2

ph-index = 1

Forward Citations = 23(Granted Patents)


Location History:

  • Milan, IT (2013)
  • Villasanta, IT (2016 - 2017)

Company Filing History:


Years Active: 2013-2017

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Laura Belvisi: Innovator in Apoptosis Induction

Introduction

Laura Belvisi is a prominent inventor based in Villasanta, Italy. She has made significant contributions to the field of cancer therapy through her innovative work on SMAC mimetic compounds. With a total of 3 patents to her name, her research focuses on the induction of apoptotic cell death, which is crucial in cancer treatment.

Latest Patents

One of Laura Belvisi's latest patents is titled "Homo- and heterodimeric SMAC mimetic compounds as apoptosis inducers." This invention relates to conformationally constrained homo- and heterodimeric mimetics of Smac that function as inhibitors of Inhibitor of Apoptosis Proteins (IAPs). The invention emphasizes the therapeutic use of these compounds, particularly in inducing apoptotic cell death, which is beneficial in cancer treatment, either alone or in combination with other active ingredients.

Career Highlights

Throughout her career, Laura has worked with notable companies such as BioNTech AG and Cisi Scrl. Her experience in these organizations has allowed her to develop her expertise in the field of apoptosis and cancer therapy.

Collaborations

Laura has collaborated with esteemed colleagues, including Pierfausto Seneci and Domenico Delia. These partnerships have further enriched her research and contributions to the scientific community.

Conclusion

Laura Belvisi stands out as an innovative inventor whose work on SMAC mimetic compounds has the potential to transform cancer therapy. Her dedication to advancing medical science is evident through her patents and collaborations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…